Deerland Probiotics & Enzymes is pleased to announce that it has earned the ISO/IEC 17025:2005 certification from the ANSI-ASQ National Accreditation Board (ANAB).
RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has made an investment in Deerland Probiotics & Enzymes (“Deerland” or the “Company”). Financial terms of the transaction were not disclosed.
DE111® Probiotic Provides Benefits for Body Fat Percentage and Athletic Performance, According to Latest Study
Researchers have found that consumption of the probiotic strain DE111® in conjunction with adequate post-workout nutrition can improve body composition and indices of athletic performance during offseason training in collegiate athletes. The study found that compared to the placebo, the probiotic DE111 produced statistically significantly improvements in the reduction of body fat percentage, and a… Read More
Deerland Probiotics & Enzymes has been granted a Natural Product Number (NPN) for Bacillus subtilis DE111, a genome sequenced and clinically studied probiotic strain that supports gut health. This new product license issuance by the Natural Health Products Directorate of Health Canada (NPN 80077102) allows DE111 to be sold throughout Canada.
Deerland Probiotics & Enzymes is pleased to announce that it has earned Non-GMO Project verification for its branded probiotic, DE111®, as well as the company’s branded prebiotic, PreforPro®.
Deerland is pleased to announce that it has completed the audit for ISO 9001:2015 certification by SGS, the world’s leading inspection, verification, testing and certification company. The International Organization for Standardization (ISO) is globally recognized for its high-quality standards, which cover a wide range of industries and processes that aim to raise the bar for… Read More
Kennesaw, Georgia, based Deerland Probiotics & Enzymes is proud to announce the launch of Digestible, an educational content portal within DeerlandEnzymes.com. The enzymes and probiotics market makes up a large part of the growing $37 billion dietary supplement industry, and its rise is driven by consumer preferences for quality supplements. According to Euromonitor International, “dietary… Read More
Washington, D.C., January 9, 2017—The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, and the International Probiotics Association (IPA), an international membership organization of probiotic companies, today announce the development of scientifically-based best practices guidelines for the labeling, storing, and stability testing of dietary supplements and… Read More
If current trends hold true, probiotic dietary supplements will be the fastest-growing supplement category in North America in 2016–2021, according to a presentation by market researcher Euromonitor at October’s SupplySide West trade show. During this time frame, North America’s probiotic supplement growth (55%) will also outpace the rest of the world’s (38%). Read more at… Read More
Deerland Probiotics & Enzymes is pleased to announce the official opening of its new, state-of-the-art facility dedicated exclusively to manufacturing probiotic-based supplement products. Production at the new Deerland Probiotics facility has begun, and the company celebrated with a ribbon-cutting ceremony this week.
Master Files and a grandfathered list are among the highlights in the FDA’s new Draft Guidance for New Dietary Ingredient Notifications. Read more at nutraingredient-usa.com.
FDA is expected to issue a revised draft document governing new dietary ingredient (NDI) notifications to the agency. Industry sources described release of the document as “imminent” and said it could be unveiled in the coming weeks in response to criticisms that the July 2011 guidance poses undue burdens to companies and is contrary to… Read More